What is Galapagos NV ADR (GLPG) stock price today?

Galapagos NV ADR (GLPG) currently trades at $27.86 per share. The stock has a market capitalization of $1.91B and a P/E ratio of 5.00x.

Is GLPG stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Galapagos NV ADR has a Smart Value Score of 74/100 (Grade B), resulting in a "Buy" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Galapagos NV ADR's revenue and earnings?

Galapagos NV ADR has trailing twelve-month (TTM) revenue of $1.11B with profit margins of 28.80%. Earnings per share (EPS) is $5.69.

Is GLPG stock overvalued or undervalued?

Based on our DCF model, Galapagos NV ADR's intrinsic value is $316.70, representing a margin of safety of 89.25%. The stock currently trades at a P/E of 5.00x.

GLPG

Galapagos NV ADR

NASDAQ: GLPG · HEALTHCARE · BIOTECHNOLOGY

$27.86

-1.97% today

Updated 2026-04-29

Market cap

$1.91B

P/E ratio

5.00

P/S ratio

1.72x

EPS (TTM)

$5.69

Dividend yield

—

52W range

$25 – $38

Volume

0.2M

Market cap

$1.91B

P/E ratio

5.00

P/S ratio

1.72x

EPS (TTM)

$5.69

Dividend yield

—

52W range

$25 – $38

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: B

Buy

Investment rating

10.0

Growth

A+

5.0

Quality

C+

8.5

Profitability

8.3

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$28.39

+1.90%

12-Month target

—

Intrinsic (DCF)

$316.70

Margin of safety

+89.25%

0 Strong Buy0 Buy3 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Profit margin 28.80% — above average

+ Revenue growth 1,093.00% QoQ

+ 89.25% below intrinsic value

Risks

- Negative free cash flow $-43.28M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$241.25M	$239.72M	$275.65M	$1.11B	$1.11B
Net income	$-217.99M	$211.70M	$74.08M	$320.90M	$782.16M
EPS	—	—	—	—	$5.69
Free cash flow	$-537.49M	$-425.24M	$-402.14M	$-202.40M	$-43.28M
Profit margin	-90.36%	88.31%	26.88%	28.85%	28.80%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GLPG	$1.91B	74	10.0	8.5	8.3	5.0	+89.25%	Strong Buy
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Galapagos NV ADR trades at $27.86. representing a P/E of 5.00x trailing earnings. Our Smart Value Score of 74/100 indicates the stock is good. TTM revenue stands at $1.11B. with profit margins at 28.80%. Our DCF model estimates intrinsic value at $316.70.

Frequently asked questions

What is Galapagos NV ADR's stock price?

Galapagos NV ADR (GLPG) trades at $27.86.

Is Galapagos NV ADR overvalued?

Smart Value Score 74/100 (Grade B, Buy). DCF value $316.70.

What is the price target of Galapagos NV ADR (GLPG)?

The analyst target price is $28.39, representing +1.9% upside from the current price of $27.86.

What is the intrinsic value of Galapagos NV ADR (GLPG)?

Based on our DCF model, intrinsic value is $316.70, a +89.3% margin of safety versus $27.86.

What is Galapagos NV ADR's revenue?

TTM revenue is $1.11B.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.72x

ROE10.40%

Beta0.15

50D MA$31.27

200D MA$32.26

Shares out0.07B

Float0.04B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GLPG vs LLY →GLPG vs JNJ →GLPG vs ABBV →Stock screener →